Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Gait Analysis in Neurological Disease

NCT: NCT02994719 · ACTIVE_NOT_RECRUITING

NCT IDNCT02994719
StatusACTIVE_NOT_RECRUITING
Start Date2016-03-01
Completion2027-07-07
SponsorBeth Israel Deaconess Medical Center (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to investigate whether speed-dependent measures of gait (so called gait signatures) can be identified in patients with neurological conditions that affect gait, particularly in subjects with parkinsonian disorders.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑